Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

Completed · Not applicable

Conditions studied: Hyperlipidemia, Diabetes, Hypertension

In brief

The study was a 12-month, multi-centered, quasi-experimental design to assess point-of-care (POCT) screening/monitoring of subjects on antipsychotic agents for metabolic syndrome. Subjects were also randomized to either an Extended Treatment Group (ETG) defined by receiving comprehensive medication management (CMM) pharmacist interventions or a Usual Treatment Group (UTG) receiving no CMM interventions. All subjects were recruited from three community mental health clinic settings in Minnesota.

Key facts

Study ID

NCT02029989

Run by

University of Minnesota

People needed

121

Starts

2010-02-01

Expected to finish

2012-02-01

Last updated by the study team

2024-04-04

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• English speaking
• Age 18-64
• Competent to understand and make medical choices independently

You may not qualify if…

• Currently or previously seen by a CMM pharmacist

Where it is running

• Human Development Center — Duluth, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.